- Home
- AVTX vs PRE Comparison
AVTX vs PRE Comparison
Compare AVTX & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- PRE
- Stock Information
- Founded
- AVTX 2011
- PRE 2014
- Country
- AVTX United States
- PRE Hong Kong
- Employees
- AVTX N/A
- PRE N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- AVTX Health Care
- PRE Industrials
- Exchange
- AVTX Nasdaq
- PRE Nasdaq
- Market Cap
- AVTX 118.6M
- PRE 102.7M
- IPO Year
- AVTX 2015
- PRE N/A
- Fundamental
- Price
- AVTX $9.88
- PRE $7.25
- Analyst Decision
- AVTX Strong Buy
- PRE Buy
- Analyst Count
- AVTX 8
- PRE 1
- Target Price
- AVTX $31.00
- PRE $9.00
- AVG Volume (30 Days)
- AVTX 335.9K
- PRE 28.2K
- Earning Date
- AVTX 08-07-2025
- PRE 10-06-2025
- Dividend Yield
- AVTX N/A
- PRE N/A
- EPS Growth
- AVTX N/A
- PRE N/A
- EPS
- AVTX N/A
- PRE N/A
- Revenue
- AVTX $441,000.00
- PRE $41,520,000.00
- Revenue This Year
- AVTX N/A
- PRE $198.17
- Revenue Next Year
- AVTX N/A
- PRE $59.73
- P/E Ratio
- AVTX N/A
- PRE N/A
- Revenue Growth
- AVTX N/A
- PRE 78.72
- 52 Week Low
- AVTX $3.39
- PRE $3.10
- 52 Week High
- AVTX $16.00
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- AVTX 76.24
- PRE 39.53
- Support Level
- AVTX $8.41
- PRE $7.21
- Resistance Level
- AVTX $9.80
- PRE $7.95
- Average True Range (ATR)
- AVTX 0.85
- PRE 0.36
- MACD
- AVTX -0.01
- PRE -0.06
- Stochastic Oscillator
- AVTX 87.52
- PRE 5.95
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.